Borr Drilling Ltd 6-K, filed May 13, 2020
Borr Drilling Ltd (BORR)
6-K
2020-05-13
For: 2020-05-13
View Original
Added on
April 10, 2026
About this 6-K
Borr Drilling Ltd filed this 6-K on May 13, 2020.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2020
Borr Drilling Limited
S. E. Pearman Building
2nd Floor 9 Par-la-Ville Road
Hamilton HM11
Bermuda
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Exhibits.
|
Exhibit
|
Description
|
|
|
Press release dated May 12, 2020
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BORR DRILLING LIMITED
|
|||
|
Date:
|
May 13, 2020
|
By:
|
/s/ Svend Anton Maier
|
|
Svend Anton Maier
|
|||
|
Chief Executive Officer
|
|||
Exhibit 99.1
Borr Drilling Limited Receives Notice from NYSE regarding Continued Listing Standard
May 12, 2020, Borr Drilling Limited (the “Company” or “Borr”) (NYSE: BORR, OSE: BDRILL), today announced that the Company has received written notice from the New York Stock Exchange (the “NYSE”) that the Company is
not in compliance with the NYSE continued listing standard with respect to the minimum average share price required by the NYSE because the average closing price of its common shares had fallen below $1.00 per share over a period of 30 consecutive
trading days.
Under the NYSE rules, the Company can regain compliance with this standard and cure this deficiency if, during the six-month period following receipt of the NYSE notice, on the last trading day of any calendar month
or on the last trading day of this six-month cure period, the Company’s common shares have a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30-trading day period ending on the last trading day of
that month or the last trading day of the cure period. Effective April 21, 2020, the NYSE has provided relief for issuers which are not compliant with the minimum $1 per share standard, providing issuers additional time to cure the non-compliance,
which for the Company means 26 December 2020. The Company has responded to the NYSE to confirm its intent to cure this non-compliance. During this period, the Company’s common shares will continue to be traded on the NYSE subject to the Company’s
compliance with other applicable NYSE listing requirements.
Hamilton, Bermuda,
May 12, 2020
Forward looking statements
This press release includes forward looking statements, which do not reflect historical facts and may be identified by words such as “plan”, “may”, “believe”, “continue”, “estimate”, “expect”, “intends”, “may”,
“should”, “will” and similar expressions and include statements relating to the notice from the NYSE as to non-compliance with the minimum price rule and the Company’s plan to regain compliance, and other non-historical statements. Such
forward-looking statements are subject to risks, uncertainties, contingencies and other factors could cause actual events to differ materially from the expectations expressed or implied by the forward-looking statements included herein, including
risks related to the Company’s ability to complete an annual general meeting and obtain approval for a reverse share split, and otherwise be able to regain compliance with NYSE rules and maintain its listing on the NYSE and other factors described
in the section entitled “Risk Factors” in our filings with the Securities and Exchange Commission. Such risks, uncertainties, contingencies and other factors could cause actual events to differ materially from the expectations expressed or implied
by the forward-looking statements included herein. These forward-looking statements are made only as of the date of this release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information,
future events or otherwise.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.